Mirae Asset Global Etfs Holdings Ltd. Denali Therapeutics Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $43.9 Billion
- Q4 2024
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Denali Therapeutics Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 85,075 shares of DNLI stock, worth $1.13 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
85,075
Previous 81,664
4.18%
Holding current value
$1.13 Million
Previous $2.38 Million
27.12%
% of portfolio
0.0%
Previous 0.01%
Shares
3 transactions
Others Institutions Holding DNLI
# of Institutions
240Shares Held
111MCall Options Held
80KPut Options Held
36.8K-
Black Rock Inc. New York, NY13.2MShares$175 Million0.01% of portfolio
-
Baillie Gifford & CO12.3MShares$163 Million0.2% of portfolio
-
Vanguard Group Inc Valley Forge, PA12MShares$160 Million0.0% of portfolio
-
Capital Research Global Investors Los Angeles, CA5.48MShares$72.7 Million0.02% of portfolio
-
Temasek Holdings (Private) LTD Singapore, U05.36MShares$71.1 Million0.55% of portfolio
About Denali Therapeutics Inc.
- Ticker DNLI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 134,174,000
- Market Cap $1.78B
- Description
- Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. It offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidate, including BIIB122/DNL151, a small molecule inhibitor, which is in phase I and phase Ib clinical trials for the treatm...